New Study Quantifies the Impact of Caring for a Child with Rare Disease PFIC

Albireo Pharma announced the publication of a study that evaluated and quantified the impact that progressive familial intrahepatic cholestasis (PFIC) has on caregivers. Understanding this impact has been challenging due to the rare nature of PFIC.

As a rare, pediatric, genetic disease of cholestasis, PFIC is characterized by inadequate bile secretion and often requires liver transplantation….

Continue Reading

News Source:

Leave a comment